Barbara Forte
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Barbara Forte has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Dario Romagnoli
Bioinformatics Unit, Hospital of Prato, Prato, Italy
1 shared publication - Diletta Dolfini
Dipartimento di Bioscienze, Università degli Studi di Milano, Milan, Italy
1 shared publication - Elena Ferrari
Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna “Bruno Ubertini”, Via Bianchi 7/9, 25124 Brescia, Italy
1 shared publication - Federica Rotundo
Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, 20133, Italy
1 shared publication Matteo Benelli
Centre for Integrative Biology, University of Trento, Trento, 38123, Italy
1 shared publication- Matteo Dugo
Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy
1 shared publication
Latest Publications
- Open Access
- 18 January 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1-18
LEADeR role of miR-205 host gene as long noncoding RNA in prostate basal cell differentiation
Though miR-205 function has been largely characterized, the nature of its host gene, MIR205HG, is still completely unknown. Here, we show that only lowly expressed alternatively spliced MIR205HG transcripts act as de facto pri-miRNAs, through a process that involves Drosha to prevent unfavorable splicing and directly mediate miR-205 excision. Notably, MIR205HG-specific processed transcripts revealed to be functional per se as nuclear long noncoding RNA capable of regulating differentiation of human prostate basal cells through control of the interferon pathway. At molecular level, MIR205HG directly binds the promoters of its target genes, which have an Alu element in proximity of the Interferon-Regulatory Factor (IRF) binding site, and represses their transcription likely buffering IRF1 activity, with the ultimate effect of preventing luminal differentiation. As MIR205HG functions autonomously from (albeit complementing) miR-205 in preserving the basal identity of prostate epithelial cells, it warrants reannotation as LEADeR (Long Epithelial Alu-interacting Differentiation-related RNA).
- 18 January 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1-18
Open AccessLEADeR role of miR-205 host gene as long noncoding RNA in prostate basal cell differentiation
Though miR-205 function has been largely characterized, the nature of its host gene, MIR205HG, is still completely unknown. Here, we show that only lowly expressed alternatively spliced MIR205HG transcripts act as de facto pri-miRNAs, through a process that involves Drosha to prevent unfavorable splicing and directly mediate miR-205 excision. Notably, MIR205HG-specific processed transcripts revealed to be functional per se as nuclear long noncoding RNA capable of regulating differentiation of human prostate basal cells through control of the interferon pathway. At molecular level, MIR205HG directly binds the promoters of its target genes, which have an Alu element in proximity of the Interferon-Regulatory Factor (IRF) binding site, and represses their transcription likely buffering IRF1 activity, with the ultimate effect of preventing luminal differentiation. As MIR205HG functions autonomously from (albeit complementing) miR-205 in preserving the basal identity of prostate epithelial cells, it warrants reannotation as LEADeR (Long Epithelial Alu-interacting Differentiation-related RNA).